See as far as potential is concerned it is huge on every single vertical.
Question is executing profitably
and delivering.
Take any vertical....derma,wh,oc,meno
Even distribution is /can be money spinner as USA is too big in pharma.
MYX exec should have all the experience and info to develop a plan
execute and prosper.If they cannot then they should move out
so that some one else can come in to do a better job.
Give current team another six months may be and let us see what they do..
See as far as potential is concerned it is huge on every single...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.57 |
Change
-0.005(0.11%) |
Mkt cap ! $387.0M | |||
| Open | High | Low | Value | Volume |
| $4.59 | $4.60 | $4.51 | $173.6K | 38.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 448 | $4.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.57 | 968 | 21 |
View Market Depth
| Last trade - 12.41pm 27/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |